Hemoglobin Measured by "Orsense NBM-200MP" Device and Laboratory Measurement
Launched by HOPITAL FOCH · Mar 22, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • emergency unit patients requiring an hemoglobin determination
- Exclusion Criteria:
- • none
About Hopital Foch
Hospital Foch is a leading healthcare institution located in Suresnes, France, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, Hospital Foch actively engages in the development of new therapeutic approaches across various medical disciplines, facilitating cutting-edge studies that aim to enhance treatment outcomes and improve patient quality of life. With a multidisciplinary team of experienced researchers and healthcare professionals, the hospital fosters a collaborative environment that prioritizes ethical standards and scientific rigor, ensuring the highest quality in clinical trial execution and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suresnes, , France
Patients applied
Trial Officials
Marc Fischler, MD
Study Chair
Hôpital Foch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials